GeneSort
Acquired
Cancer, Genomics, Healthcare

Business Overview

GeneSort is an innovative genomic diagnostic company for cancer.
GeneSort delivers preventative medicine solutions for healthy and better cancer care for the sick.

Founded
January 2014
Business model
B2B
Total funding
$2.2 Million
Investors
Sectors
Cancer, Genomics, Healthcare, Next Generation Sequencing

Exit Events and Acquisitions

Date Announced

Transaction

Consideration

Target

Acquirer

May 2017
Acquisition
$23 M
AID Partners

Similar Startups

Related Investors

Sign up for free

  • Save profiles to your list
  • View all funding rounds
  • Advanced sorting filter access
  • Search investment rounds
  • Search exit events

Sign up for Pro

  • Export lists (CSV, Excel) of startups and investors
  • View newly added AI startups
  • View investor emails
  • View investment funds and rounds sources
  • Advanced filters, sorting and search
  • Starting at just $15 per month